Liver and Kidney Regeneration Experts are making significant strides in developing transformative therapies to regenerate these vital organs, offering new hope to patients with chronic organ diseases. However, when these organs become severely damaged due to diseases like cirrhosis, nephropathy, or genetic disorders, they often lose their ability to regenerate naturally. These experts are focusing on innovative approaches like stem cell therapies, tissue engineering, and gene editing to stimulate tissue repair and restore the function of these critical organs. Their goal is to reduce the need for organ transplants and improve long-term health outcomes for patients suffering from organ failure.
Liver and kidney regeneration experts are developing new regenerative therapies while also addressing the challenges of immune rejection, fibrosis, and effective tissue integration. By leveraging cutting-edge techniques like 3D bioprinting, bioactive scaffolds, and growth factor delivery systems, they aim to optimize healing and tissue growth in the liver and kidneys. Through these advancements, they are working toward creating personalized, sustainable solutions that can help patients recover from organ damage without the need for a transplant. As research in this area progresses, these experts are reshaping the future of regenerative medicine and providing new avenues for treating chronic liver and kidney diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States